Summary:
Clinical research study of an investigational medication in the treatment of people with Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis OR Compensated Liver Cirrhosis.
Qualified Participants Must:
Be between 18 and 75 years of age
Have a liver biopsy that is consistant with NASH and stage 3 liver fibrosis OR compensated liver cirrhosis
Qualified Participants May Receive:
Compensation available for time and travel